JENNE KYLE (EVP, Chf GL Pdt Str Ofcr) sold 17.1% of their position (4.90K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $368.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/17/2026ACC: 0000874015-26-000171
Officer· EVP, Chf GL Pdt Str Ofcr
Since Mar 2026
-4.90K
Net shares
Net seller
$368.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.23K acquired · 17.13K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.23K
Price / share
—
Trade value
—
% of position
74.6%
4/15/2026
16.39K→28.61K
Common Stock
Direct
Shares
−4.90K
Price / share
$75.17
Trade value
$368.49K
% of position
17.1%
4/16/2026
28.61K→23.71K
Total
Net shares
+7.32K
Net value
-$368.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2026 | M · Option Exercise | +12.23K | — | — | 74.6% | 16.39K | 28.61K |
| Common Stock Direct | 4/16/2026 | S · Sale | −4.90K | $75.17 | $368.49K | 17.1% | 28.61K | 23.71K |
| Total | +7.32K | -$368.49K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
12.23K shares
Shares
−12.23K
Strike price
0.0
Held after
74.40K
Exercisable
—
4/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock12.23K shares | 4/15/2026 | M · Option Exercise | −12.23K | 0.0 | — | 74.40K |